MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Case Report: Co-occurrence of Motor Neuron Disease and Parkinsonism

    B. Barton (Chicago, IL, USA)

    Objective: Explore possible links between degenerative parkinsonism and motor neuron disease Background: A 50 year-old man developed with the cardinal features of parkinsonism.  History was…
  • 2019 International Congress

    Cholecalciferol (VD3) attenuated motor deficits and dyskinesia in Hemi-Parkinsonian mice: behavioural, biochemical & electrophysiological implications

    A. Bayo-Olugbami, A. Oyewole, A. Nafiu, A. Amin, B. Ogundele, B. Owoyele, C. Lee (Ilorin, Nigeria)

    Objective: The study investigated the impacts of VD3 on behavioural indices, dopamine metabolism, DA transport, BDNF, corticostriatal neural activities and the possible mechanism of action…
  • 2019 International Congress

    Daytime Sleepiness Effects on Motor Symptoms in De Novo Parkinson’s Disease

    E. Bayram, R. Yilmaz, K. Longardner, M. Akbostanci, I. Litvan (La Jolla, CA, USA)

    Objective: To investigate whether daytime sleepiness in newly diagnosed Parkinson’s disease (PD) patients predicts future dependency. Background: Excessive daytime sleepiness (EDS) is one of the…
  • 2019 International Congress

    Characteristics and outcome of patients with Parkinson’s disease admitted to intensive care unit

    O. Benhadj Salem, S. Demeret, A. Demoule, F. Bolgert, H. Outin, T. Sharshar, D. Grabli (Paris, France)

    Objective: To study the characteristics and the outcome of patients with Parkinson's disease admitted to intensive care unit. Background: Whereas Parkinson’s disease is associated with…
  • 2019 International Congress

    Medical management after subthalamic nucleus deep brain stimulation in patients with Parkinson’s Disease

    A. Bertholo, R. Cury (São Paulo, Brazil)

    Objective: The present study aims to: i) systematically evaluate literature data on acute medical management after subthalamic nucleus (STN) deep brain stimulation (DBS)  and, ii)…
  • 2019 International Congress

    Assessment of neuronal morphology to determine the differential susceptibility to Parkinson’s disease using MPTP in two genetically distinct mice strains

    B. Bhaduri, I. Datta, R. Yadav, P. Alladi (Bangalore, India)

    Objective: To delineate the contribution of neuronal-dendritic structure in the substantia nigra and striatum, in conferring differential susceptibility to Parkinson’s disease, using two genetically distinct…
  • 2019 International Congress

    Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism

    M. Bhargava, S. Bhargava (Kanpur, India)

    Objective: In the present investigation, amino acid coupled liposomes bearing dopamine-HCl were prepared to deliver drug to the brain utilizing receptor-mediated transcytosis for effective management…
  • 2019 International Congress

    Abnormal Intracortical Facilitation in patients of Parkinson’s disease with REM Sleep Behavior Disorder

    A. Bhattacharya, N. Kamble, R. Yadav, PK Pal

    Objective: To evaluate the motor cortical excitability changes in PD patients with and without RBD. Background: There has been an increase in the understanding of…
  • 2019 International Congress

    Frequency of impulse control disorder in Parkinson’s disease: insights from the Luxembourg cohort

    S. Binck, C. Pauly, P. Kolber, L. Pavelka, L. Stute, D. Reiter, M. Vaillant, M. Gantenbein, E. Glaab, J. Ferrand, L. Geffers, G. Hipp, R. Krueger, NJ. Diederich (Strassen, Luxembourg)

    Objective: To establish the frequency of impulse control disorder (ICD) in idiopathic Parkinson’s disease (IPD) and analyze contributing factors. Background: To establish the frequency of…
  • 2019 International Congress

    Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson’s disease : a large single-center study

    A-S. Blaise, G. Baille, N. Carrière, D. Devos, K. Dujardin, G. Grolez, A. Kreisler, M. Kyheng, C. Moreau, E. Mutez, D. Seguy, L. Defebvre (Lille, France)

    Objective: To describe adverse events (AEs) associated with levodopa-carbidopa intestinal gel (LCIG) treatment and the main reasons for treatment discontinuation. We also assessed the effectiveness…
  • « Previous Page
  • 1
  • …
  • 1271
  • 1272
  • 1273
  • 1274
  • 1275
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley